Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 70,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 70,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 15,470 | 18,275 | 18,130 | 22,130 | 20,246 |
| Operating Income | 54,530 | -18,275 | -18,130 | -22,130 | -20,246 |
| Other Income | 2,012 | 2,290 | 2,573 | 2,221 | 2,021 |
| Pre-tax Income | 56,542 | -15,985 | -15,557 | -19,909 | -18,225 |
| Net Income Continuous | 56,542 | -15,985 | -15,557 | -19,909 | -18,225 |
| Net Income | $56,542 | $-15,985 | $-15,557 | $-19,909 | $-18,225 |
| EPS Basic Total Ops | 1.00 | -0.28 | -0.28 | -0.36 | -0.35 |
| EPS Basic Continuous Ops | 1.00 | -0.28 | -0.28 | -0.36 | -0.35 |
| EPS Diluted Total Ops | 0.98 | -0.28 | -0.28 | -0.36 | -0.35 |
| EPS Diluted Continuous Ops | 0.98 | -0.28 | -0.28 | -0.36 | -0.35 |
| EPS Diluted Before Non-Recurring Items | 0.98 | -0.28 | -0.28 | -0.36 | N/A |
| EBITDA(a) | $54,617 | $-18,190 | $-18,044 | $-22,044 | $-20,160 |